The U.S. Court of Appeals for the District of Columbia has unveiled the schedule for the next step of the Cigar Association of America et al. v. United States Food and Drug Administration et al., the seven-year lawsuit filed by three cigar trade groups against the U.S. Food & Drug Administration’s (FDA) deeming regulations.
In August, Judge Amit P. Mehta ruled in favor of the cigar groups, but the Department of Justice, which represents the FDA in legal matters, filed an appeal.
The appeals court has ordered the following schedule for briefs:
- Appellants’ Brief — Jan. 16, 2024
- Appendix — Jan. 16, 2024
- Appellee’s Brief — Feb. 15, 2024
- Appellants’ Reply Brief — March 7, 2024
Notably, these deadlines all pertain to paperwork and not a date when the parties will argue the case in front of a three-judge panel.
Mehta’s August 2023 ruling determined the form of remedy; the judge had already decided in July 2022 that the FDA erred when considering how to regulate premium cigars. Specifically, he found the agency ignored comments that showed that premium cigars—larger, unflavored cigars—were not used in the same way as their smaller and oftentimes flavored counterparts.
After more than seven years, Mehta opted to vacate the rule for cigars that met a definition of “premium cigars,” meaning those cigars were no longer subject to FDA’s deeming regulations, such as testing requirements, user fees and a ban on giving away those cigars for retail promotions or charitable donations.
The Department of Justice has not filed for any sort of injunction, meaning cigars that meet the definition of “premium cigar” are not subject to those regulations.